Pure Global AI
NCT06265831Recruitment Completed

The Effect of Face Hand Fan Application on Dyspnea

The Effect of Face Hand Fan Application on Dyspnea and Quality of Life in COPD Patients
Bartın UnıversityClinicalTrials.govother
Study focus
Disease/Condition
COPD
Drug/Device/Intervention
Hand-fan application to the face
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Bartın Unıversity
Location
Bartın, Turkey
Timeline & enrollment
Phase
N/A
Start date
Apr 01, 2023
End date
Mar 01, 2024
Enrollment
61 participants
Primary outcome

Modified Borg Scale

Summary

Diagnosing and managing dyspnea in patients with COPD is very important. Although
 pharmacological and non-pharmacological methods are used in the management of dyspnea, it is
 recommended that pharmacological methods be supported by non-pharmacological methods. Hand
 fan application, which is one of the non-pharmacological methods used in dyspnea management,
 provides an increase in self-efficacy in patients in addition to the stimulation of cold air
 flow to the trigeminal nerve branches, mucosa and skin. Although there are studies reporting
 that applying cold air to the face with a hand fan is effective in reducing the severity of
 dyspnea in different patient groups, the number of studies examining the effectiveness of
 applying cold air to the face with a hand fan in patients with COPD is quite limited. This
 project was planned to determine the effect of applying cold air to the face with a fan on
 the severity of dyspnea and quality of life in COPD patients.

ICD-10 classifications
Chronic obstructive pulmonary disease, unspecifiedOther chronic obstructive pulmonary diseaseOther specified chronic obstructive pulmonary diseaseChronic obstructive pulmonary disease with acute exacerbation, unspecifiedPulmonary heart disease, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06265831
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06265831 through Pure Global AI's free database. This phase not specified trial is sponsored by Bartın Unıversity and is currently Recruitment Completed. The study focuses on COPD. Target enrollment is 61 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.